Paul A. Friedman
Overview
Paul A. Friedman received an average of $4M in total compensation, including $468K in salary, at Synta Pharmaceuticals from 2016 to 2021. Paul Friedman also received an average of $2M at Incyte from 2006 to 2014.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2014
- 2013
- 2012
- 2011
Synta PharmaceuticalsChairman and Chief Executive Officer
Synta PharmaceuticalsChairman and Chief Executive Officer
Synta PharmaceuticalsChairman and Chief Executive Officer
Synta PharmaceuticalsChairman and Chief Executive Officer
Synta PharmaceuticalsChief Executive Officer
Synta PharmaceuticalsChief Executive Officer
IncyteFormer President and Chief Executive Officer
IncyteFormer President and Chief Executive Officer
IncyteFormer President and Chief Executive Officer
IncyteFormer President and Chief Executive Officer
Source: SEC filings on May 2, 2022, April 29, 2020, May 15, 2019, April 27, 2018, April 13, 2015, April 22, 2014, April 18, 2013, April 18, 2012, April 8, 2009, April 7, 2008, and April 6, 2007.
Related executives
We found 35 more executives who work or worked at Synta Pharmaceuticals and Incyte.
Hervé Hoppenot
Incyte
Chief Executive Officer
Steven Stein
Incyte
Chief Medical Officer
Alex Howarth
Synta Pharmaceuticals
Chief Financial Officer
Christiana Stamoulis
Incyte
Chief Financial Officer
Rebecca Taub
Synta Pharmaceuticals
Chief Medical Officer
Barry Flannelly
Incyte
Executive Vice President and General Manager, NA
Maria Pasquale
Incyte
General Counsel
Marc Schneebaum
Synta Pharmaceuticals